当前位置: 首页 > 期刊 > 《中国当代医药》 > 202020
编号:13829046
双相情感障碍丙戊酸钠治疗过程中POLG基因突变1例分析(4)
http://www.100md.com 2020年7月15日 《中国当代医药》 202020
     [20]Sitarz KS,Elliott HR,Karaman,Betül S,et al.Valproic acid triggers increased mitochondrial biogenesis in POLG-deficient fibroblasts[J].Mol Genet Metab,2014,112(1):57-63.

    [21]Rajakulendran S,Pitceathly RDS,Taanman JW,et al.A Clinical,Neuropathological andGenetic Study of Homozygous A467T POLG-Related Mitochondrial Disease[J].PLoS One,2016,11(1):e0145500.

    [22]Hynynen J,Komulainen T,Tukiainen E,et al.Acute liver failure in patients withPOLG1 mutations after valproate exposure and their prognosis after liver transplantation[J].Liver Transpl,2014,20(11):1402-1412.

    [23]London F,Hadhoum N,Outteryck O,et al.Late-onset of Alpers-Huttenlocher syndrome:an unusual cause of refractory epilepsy and liver failure[J].Acta Neurol Belg,2017,117(1):399-401.

    [24]Saneto RP,Lee IC,Koenig MK,et al.POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders[J].Seizure,2010, 19(3):140-146.

    [25]丙戊酸鈉缓释片说明书[EB/OL].https://baike.baidu.com/item/丙戊酸钠缓释片/865696?fr=aladdin.

    (收稿日期:2019-12-02), http://www.100md.com(刘超 易正辉 吕钦谕 王培涓)
上一页1 2 3 4